Tamar Jablonski-Perec

所在地：イスラエル, エルサレム
クリニック：
4.4
Hadassah Medical Center
Tamar Jablonski-Perec is an oncologist at the Hadassah Medical Center who received her Doctor of Medical Sciences at the Hebrew University in Jerusalem and completed an internship at the renowned Sloan-Kettering Cancer Center in New York. Her key takeaways include:
- Head of Institute of Oncology in 1994
- Head of Breast Cancer Treatment Center in 1998
- Professor of the Department of Oncology at the Hebrew University in 2006
- Member of several international cancer communities
- Awarded a scholarship from the Hadassah Medical School
続きを読む

診察

お問い合わせください

Bookimed洞察：イスラエルのトップ化学療法専門家（2026）

Bookimedはイスラエルの化学療法リクエスト16件を調整し、1名のトップ評価専門家と協力しています。この表の医師は国際的資格、臨床専門知識、患者の結果に基づいて選ばれています。2026年ランキングは実際の患者ケースとパートナークリニックの現行プログラムからの検証済みデータを使用して形成されています

順位	医師	経験	適合する方	特色	クリニックと所在地	診察

FAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

Can I get a second opinion from an Israeli chemotherapy doctor remotely?

You can receive a remote second opinion from Israeli chemotherapy doctors via video consultation. Leading oncologists at JCI-accredited centers like Sourasky Medical Center review your diagnosis and treatment plans digitally. These specialists often hold board certifications in oncology and radiotherapy and possess international fellowship training.

Specialist access: Consult with experts like Prof. Dr. Ofer Merimsky for rare sarcomas.
Consultation fees: Private video sessions with senior oncologists typically range from $750 to $1,050.
Genomic medicine: Doctors like Dr. Ari Raphael provide expert reviews of genomic-guided therapies.
Pediatric expertise: Dr. Dror Levin offers specialized second opinions for bone tumors in children.

Bookimed Expert Insight: Israeli oncology care is highly collaborative. Senior doctors like Dr. Pelles Sharon and Dr. Ido Wolf often lead research units within the same hospital. This means a single remote consultation can provide insights into both standard chemotherapy and clinical trials for immunotherapy or targeted treatments. Reviewing these options together often leads to more personalized protocol adjustments.

Patient Consensus: Patients note that the process from initial contact to diagnosis is remarkably fast. Many emphasize the importance of having a dedicated coordinator to navigate the hospital system and handle logistics. While some found communication after the session required middle-man support, they felt the medical equipment and expertise justified the investment.

Who are the top chemotherapy specialists in Israel?

Top chemotherapy specialists in Israel include world-renowned oncologists like Prof. Dr. Ofer Merimsky and Prof. Dr. Nir Peled. These experts hold leadership roles in national oncology societies. Many have extensive training from elite institutions like Sloan-Kettering and Oxford University.

Surgical Oncology: Dr. Pelles Sharon specializes in advanced HIPEC and personalized chemotherapy protocols.
Rare Tumors: Prof. Dr. Ofer Merimsky is a leading authority on sarcomas and bone tumors.
Breast Cancer: Prof. Dr. Tamar Jablonski-Perec leads breast cancer treatment with Sloan-Kettering training.
Genomic Medicine: Dr. Ari Raphael pioneers genomic-guided therapies and immunotherapy for thoracic malignancies.

Bookimed Expert Insight: Data shows a strong pattern of international fellowship training among Israel's top oncologists. Dr. Dvora Blumental trained at Memorial Sloan-Kettering, while Dr. Pelles Sharon specialized at Royal Marsden in London. This global exposure allows them to implement innovative chemotherapy protocols often before they become standard elsewhere. Dr. Ari Raphael even leads Israel's national genomic medicine initiative at Sourasky Medical Center (Ichilov), providing highly targeted treatments.

Patient Consensus: Patients note that the diagnostic process and blood tests are exceptionally fast. They appreciate the access to new equipment and advanced chemo regimens. Many feel a genuine sense of care from the local hospital teams during their treatment journey.

How quickly can an Israeli chemotherapy doctor start treatment after diagnosis?

Israeli chemotherapy doctors typically start treatment within 3 to 7 days after a definitive diagnosis. Private facilities often accelerate this timeline to just 4 days following biopsy confirmation. Specialized oncologists at JCI-accredited centers prioritize rapid intervention for aggressive cases to improve patient results.

Private medical centers: Treatment planning usually takes 3 days with next-day chemotherapy initiation possible.
Diagnostic confirmation: Pathological reviews and PET-CT imaging are often completed within 3 to 10 days.
Genetic testing: Molecular profiling for targeted therapies can slightly extend the initial preparation window.
Urgent cases: Aggressive malignancies receive priority with treatment starting in under 14 days.

Bookimed Expert Insight: Data shows that senior oncologists at Sourasky Medical Center, such as Dr. Irina Stepfansky and Dr. Ari Raphael, lead national genomic initiatives. This allows for molecular profiling and chemotherapy planning to happen simultaneously. Patients can access personalized protocols faster than the standard European wait times of 2 to 4 weeks.

Patient Consensus: Patients are often surprised by how quickly they move from the first consultation to their first dose. Many note that the process feels very well organized and fast. They highlight that finishing all tests and starting treatment within a few days provides immense relief.

Do Israeli doctors provide targeted chemotherapy?

Israeli doctors provide targeted chemotherapy as a standard part of precision oncology. Leading specialists perform detailed molecular testing to identify specific genetic mutations. They use this data to select medications that attack cancer cells while sparing healthy tissue for personalized treatment plans.

Precision diagnostics: Specialists use genomic profiling to identify targets like HER2, BRCA, or EGFR mutations.
Advanced therapies: Clinics offer monoclonal antibodies and tyrosine kinase inhibitors for lung and breast cancers.
Integrated care: Doctors often combine targeted agents with immunotherapy to improve overall therapy outcomes.
Clinical research: Patients can access cutting-edge targeted drugs through active clinical trials at major centers.

Bookimed Expert Insight: Data shows that top Israeli oncologists often hold significant international fellowship training. Dr. Ofer Merimsky trained at the Institut Gustave Roussy in France, while Dr. Pelles Sharon specialized at the Royal Marsden in London. This global background allows them to implement the latest international protocols for rare sarcomas and complex gastrointestinal tumors immediately.

Patient Consensus: Patients note that doctors frequently adjust therapy mid-course based on real-time scan results. They appreciate how quickly they can start new targeted drugs compared to other systems. Many say the process from initial testing to starting the first dose is very fast.

How experienced are chemotherapy doctors in Israel compared to other countries?

Israeli chemotherapy doctors are globally recognized for combining rigorous local specialization with advanced international fellowships. Many experts, like Dr. Dvora Blumental, completed training at top-tier centers like Memorial Sloan-Kettering. This dual exposure allows them to apply the latest global protocols with exceptional precision.

International training: Many oncologists hold fellowships from prestigious institutions in the USA and Europe.
Genomic expertise: Doctors like Dr. Ari Raphael lead national initiatives in genomic-guided cancer therapy.
Clinical research: Senior specialists frequently serve as principal investigators for international phase I-III trials.
Broad experience: Experts often have 30+ years of focused experience in complex oncology cases.

Bookimed Expert Insight: Data shows Israeli oncologists often hold highly specialized leadership roles in rare departments. For example, Prof. Ofer Merimsky directs a unit specifically for bone and soft tissue sarcomas. This level of niche focus, paired with consultations starting from $750, provides patients with access to world-class expertise in rare tumor types.

Patient Consensus: Patients often feel the medical teams are like a special forces unit due to their decisive approach. They appreciate how doctors use real-time genomic testing to personalize doses and minimize side effects. Many note that the process from diagnosis to starting treatment happens much faster than in other countries.

Do Israeli chemotherapy doctors use the same protocols as elsewhere?

Israeli chemotherapy doctors follow international protocols from ESMO and NCCN as the standard of care. These experts often enhance global benchmarks with personalized genomic testing. Top specialists integrate targeted biological agents to improve results for complex cases while maintaining strict international evidence-based guidelines.

International training: Professors like Dr. Ofer Merimsky have 25+ years of experience with US and European training.
Advanced credentials: Surgeons like Dr. Dvora Blumental hold fellowships from Memorial Sloan-Kettering Cancer Center in New York.
Precision oncology: Doctors adapt standardized regimens based on real-time biological analysis for each individual patient.
Cutting-edge access: Patients can access innovative chemo-biologic therapies through active clinical research and phase I-III trials.

Bookimed Expert Insight: Israeli oncology stands out because senior leaders often hold simultaneous faculty positions in European medical groups. For example, Dr. Ofer Merimsky at Sourasky Medical Center is an ESMO faculty member. This dual role means patients receive treatment from the very experts who help write the international protocols used worldwide.

Patient Consensus: Patients note that the chemotherapy regimens feel identical to those in the US or Europe. They often mention feeling relieved by how fast the diagnostic process moves. Many were surprised by the high quality of local medications that make treatment efficient and reliable.

Can patients choose their own doctor in Israeli hospitals?

Patients in Israel can choose their doctor by opting for private medical services or international patient programs. While the public system assigns oncologists based on hospital shifts, private facilities and specialized units allow direct selection of experts with international fellowships and board certifications.

Private medical service: Programs like SHARAP at hospitals such as Hadassah allow for specific doctor selection.
Center specialties: Choosing a hospital like Ichilov provides access to leaders in soft tissue sarcomas.
International training: Many selected specialists hold fellowships from Memorial Sloan-Kettering or the Royal Marsden.
Direct consultations: Expert oncologists offer private consultations in Tel Aviv starting from $750 to $1,050.

Bookimed Expert Insight: Data shows that top-tier oncologists like Dr. Ofer Merimsky and Dr. Dvora Blumental at Sourasky Medical Center often lead highly specialized units. Choosing a doctor based on their specific departmental leadership, such as neuro-oncology or sarcoma services, typically ensures more consistent care than general oncology assignments. This specialized focus often results in personalized chemotherapy protocols designed by researchers who lead national genomic initiatives.

Patient Consensus: Patients note that being assigned different doctors during public treatment can lead to inconsistent communication. They often feel more at ease in private settings where they maintain a continuous connection with one specialist. Many emphasize that having a dedicated coordinator helps manage the fast-paced testing and diagnostic process effectively.

What should I ask an Israeli chemotherapy doctor at the first visit?

When meeting an Israeli oncologist, ask about the specific chemotherapy regimen and evidence for its efficacy. Request a detailed breakdown of cycles and doses. Inquire how your treatment integrates targeted therapies or clinical trials. Focus on clarifying long-term side effect management and fertility preservation options.

Treatment protocol: Ask why this specific drug combination was chosen over other chemotherapy alternatives.
Genetic testing: Inquire if molecular profiling or genetic tests can refine your chemotherapy dosage.
Side effect prevention: Question specific strategies for preventing neuropathy and managing cumulative fatigue during cycles.
Clinical trial eligibility: Ask if you qualify for cutting-edge trials at research centers like Sourasky.

Bookimed Expert Insight: Data shows that leading Israeli oncologists often hold dual international roles. For instance, Dr. Ofer Merimsky at Sourasky Medical Center is an ESMO faculty member. These doctors often have access to international protocols before they become standard. Patients should ask if their treatment plan aligns with the latest European or American oncology society guidelines.

Patient Consensus: Patients note that doctors in Israel are often open to discussing second opinions within the competitive medical system. Many were surprised by the availability of cutting-edge trials not initially mentioned. They recommend asking for a full cost breakdown including supportive drugs to avoid unexpected fees.

What are the primary hospitals for chemotherapy treatment in Israel?

Israel features several leading hospitals for chemotherapy, including Sourasky Medical Center, Hadassah, and Rambam. These centers integrate advanced genomic testing and personalized medicine into oncology protocols. Expert oncologists often hold fellowships from top global institutions like Memorial Sloan-Kettering and Royal Marsden.

Sourasky Medical Center (Ichilov): A JCI-accredited facility recognized by Newsweek as a leading specialized hospital.
Hadassah Medical Center: Home to the Sharett Institute and a pioneer in multidisciplinary cancer care.
Rambam Medical Center: Features the Joseph Fishman Oncology Center and is ESMO-certified for clinical excellence.
Assuta Medical Center: A premier private hospital offering personalized chemotherapy units and shorter wait times.

Bookimed Expert Insight: Many leading Israeli oncologists possess high-level international training and dual specializations. For example, Dr. Ofer Merimsky at Sourasky Medical Center is an ESMO faculty member who trained in Paris, while Dr. David Sarid studied cancer urology at Oxford University. This allows patients access to global expertise within a single clinical team.

Patient Consensus: Patients often mention the comfort of receiving treatments from doctors who speak multiple languages fluently. Many were surprised by the personalized attention, noting that the medical staff explained every step of the chemotherapy process clearly. They frequently highlight the efficiency of the coordination between diagnostic testing and the start of treatment.

What should patients ask their Israeli oncologist during the first visit?

When meeting an oncologist in Israel, patients should focus on personalized data and advanced options. Top specialists define your treatment using specific genetic markers and national registry data. Inquire about exact staging, eligible clinical trials, and how therapies like immunotherapy or targeted biological agents integrate with your chemotherapy plan.

Genomic markers: Ask which genetic or hormone markers specifically guided your unique chemotherapy protocol.
Clinical trials: Inquire about Phase II chemotherapy combinations currently available only within Israeli hospitals.
Registry data: Request your stage-specific survival statistics based on the latest Israeli national medical data.
Multidisciplinary 5-year outlook: Ask how surgeons and radiation experts collaborated on your integrated care plan.

Bookimed Expert Insight: Leading Israeli oncologists often hold dual international roles. For example, Dr. Ofer Merimsky at Sourasky Medical Center is an ESMO faculty member. These connections provide patients with protocols that match or exceed those in the USA or Europe. This global integration often grants faster access to new drug combinations for rare sarcomas or complex lung cancers.

Patient Consensus: Patients note that the diagnostic process in Tel Aviv is exceptionally fast. They often feel a genuine sense of care from the medical staff. Many recommend having a clear list of questions ready as the hospital environment is very efficient.

What is the process for international patients to see an oncologist in Israel?

International patients typically see an oncologist in Israel within 7 to 10 days of submitting medical records. The process involves a document review, a specialized consultation, and diagnostic verification. Expert oncologists like Dr. Ofer Merimsky often provide a preliminary plan before the patient travels.

Medical review: Doctors evaluate biopsy slides and imaging reports within 48 hours of submission.
Financial deposit: Clinics usually require a deposit to issue an official medical invitation letter.
Travel authorization: Patients from visa-free countries must register for an online ETA-IL starting 2025.
Onsite consultation: The first meeting with a specialist usually occurs within 24 hours of arrival.

Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center (Ichilov) prioritize speed by having pathologists re-verify external biopsy slides immediately. Data shows that patients can start personalized chemotherapy protocols just days after their first visit. For those seeking remote options, specialists like Dr. Pelles Sharon and Dr. Ido Wolf offer online consultations starting from $750 to $825.

Patient Consensus: Patients note that the process moves very quickly once medical records are sent. They appreciate that coordinators help with invitation letters and local logistics. Many survivors mention that having a translator makes the complex diagnosis much easier to understand.

エルサレムで最高の化学療法医師 - トップ1名の医師

イスラエルの3名のトップ化学療法専門家から見積もりを取得

医師サービスで最良価格の国を選択